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Abstract
Background: cAMP signaling produces dramatic changes in astrocyte morphology and physiology. However, its
involvement in phenotype acquisition and the transcriptionally mediated mechanisms of action are largely
unknown.
Results: Here we analyzed the global transcriptome of cultured astroglial cells incubated with activators of cAMP
pathways. A bulk of astroglial transcripts, 6221 annotated genes, were differentially regulated by cAMP signaling.
cAMP analogs strongly upregulated genes involved in typical functions of mature astrocytes, such as homeostatic
control, metabolic and structural support to neurons, antioxidant defense and communication, whereas they
downregulated a considerable number of proliferating and immaturity-related transcripts. Moreover, numerous
genes typically activated in reactive cells, such as scar components and immunological mediators, were repressed
by cAMP. GSEA analysis contrasting gene expression profiles with transcriptome signatures of acutely isolated
astrocytes and in situ evaluation of protein levels in these cells showed that cAMP signaling conferred mature and
in vivo–like transcriptional features to cultured astrocytes.
Conclusions: These results indicate that cAMP signaling is a key pathway promoting astrocyte maturation and
restricting their developmental and activation features. Therefore, a positive modulation of cAMP signaling may
promote the normal state of differentiated astrocytes and favor the protection and function of neuronal networks.
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Background
Mature astrocytes ensheath synapses and fine blood
vessels, within the neuro-glio-vascular units, to shape
the functional micro-architecture of the central nervous
system (CNS). Through an array of transporters, ion
channels and released and adhesion molecules, astro-
cytes play key roles in the regulation of extracellular
fluid homeostasis, integrity of the blood–brain barrier
and assurance of metabolic demand and antioxidant
defense of neurons. Astrocytes also make a crucial con-
tribution to communication, operating within glial
networks through gap junctions and hemichannels and
bidirectionally with neurons and endothelial cells via
diffusible and surface molecules [1–4]. Characteristic-
ally, in response to CNS insults, such as trauma,
epilepsy or degenerative diseases, astrocytes become
reactive and play a critical role in neuroinflammation
and scar formation [4].
In contrast to neurons, little is known about the intra-
cellular signaling of astrocytes, and the pathways
controlling their differentiation and activation have not
been elucidated. By means of STAT transcription factors,
cytokines of the interleukin-6 family are key cues in the
specification and differentiation of astroglial cells. More-
over, Smad transcription factors activated by bone
morphogenetic proteins also promote astrogliogenesis,
through their interaction with STAT3 [5]. Strikingly,
analysis of glial activation in pro-inflammatory cytokine-
administered and genetically-modified mice has shown
that JAK-STAT3 signaling is also a key pathway through
which astrocytes become reactive [6]. In addition to
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activating kinase-dependent receptors, G-protein coupled
receptors can trigger astroglial genesis and maturation via
cAMP [7–11]. Changes in cell morphology and protein
expression induced by cAMP have long been considered a
feature of astrocyte activation [12–16]. However, the pre-
cise significance of the cAMP pathway in the maturation
and activation of these cells remains elusive. Here we
studied the net impact of the cAMP signaling pathway on
astrocytes by analyzing the global transcriptome of
cultured cells incubated with permeable cAMP analogs.
Moreover, we perform Gene Set Enrichment Analysis
(GSEA) of cAMP-regulated genes and contrasted our
findings with recent microarray reports and the in vivo
expression patterns of astrocytes. Our findings show that
the overall impact of the cAMP signaling pathway in
astrocytes is to promote maturation and restrict develop-
mental and activation features.
Results and discussion
Genome-wide transcriptional regulation in astrocytes by
cAMP signaling
To activate cAMP signaling we augmented intracellular
levels by exposing cultured astrocytes to the permeable
cAMP analog 8Br-cAMP. Before and after treatment cell
cultures were essentially formed by astrocytes (>95 %
GFAP+ cells). Sustained elevated intracellular cAMP
levels altered the number and morphology of astrocytes.
Quantitative analysis showed almost 25 % less GFAP+
astrocytes after treatment compared with controls
(54.21 ± 0.78 cell/mm2 and 72.08 ± 1.24 cell/mm2, re-
spectively, p = 0.006). In agreement with previous stud-
ies [7, 17], control flat polygonal-shaped astroglial cells
were converted into process-bearing stellate astrocytes
(Fig. 1). Microarray analysis showed that 6221 of 16,594
annotated genes with assigned gene symbol were differ-
entially expressed by a factor of 1.2 or greater (and
FDR q-value <0.05) in 8Br-cAMP-treated astrocytes.
The full list of differentially expressed genes is shown
in Additional file 1: Table S1. Approximately, one-third
of the regulated elements on the array corresponded to
ESTs and genes of unknown function. Of the 6221
genes with significant regulation 42.1 % were upregu-
lated by cAMP while the rest were downregulated.
We validated the present array results by analyzing astro-
cyte expression of the mRNA and protein of 10 representa-
tive genes after cAMP augmentation (Figs. 1 and 2). qPCR
analysis was performed on the cell cycle regulator cyclin
D1 (Ccnd1), the peptidase inhibitor cystatin C (Cst3), the
calcium-dependent exocytotic SNARE Vamp2, the NMDA
receptor subunit NR2C (Grin2c), the adhesion component
claudin 10 (Cldn10) and the thyroid hormone transporter
Slco1c1. A correlation was found between RT-qPCR and
array results for each gene (Fig. 2a). cAMP-induced
changes of cyclin D1, cystatin C, Vamp2 and the apoptotic
regulator Bid, as well as their time dependence, were fur-
ther corroborate at protein level by immunoblotting
(Fig. 2b). No changes on the array were found for non-
regulated genes, as shown for the ubiquitous exocytotic
protein Snap23 (Fig. 2b). Immunofluorescence for the pro-
liferation marker Mki67, the polyamine enzyme Ssat (Sat1)
and the NR2C receptor demonstrated that cAMP-
dependent gene regulation occurred in GFAP-identified
astrocytes (Fig. 1). Furthermore, previous studies showing
that cAMP regulates the expression of intermediate fila-
ments (GFAP and Nes), glutamate transporters (Slc1a2
and Slc1a3), deiodinases (Dio2), and secretogranins (Scg2
and Scg3) in astrocytes [8, 9, 18, 19] and Additional file 1:
Table S1.
cAMP-induced changes in functional expression profiles
of astrocytes
The functional roles of up- and downregulated cAMP-
responsive genes were categorized by Gene Ontology
enrichment analysis using GSEA. GO categories with
GSEA q-value <2 % were considered relevant. We calcu-
lated the relative proportion of genes in the core enrich-
ment of each GO category and grouped them in general
categories (Fig. 3). All the GO categories enriched with
differentially regulated genes are shown in the bar plot
of Additional file 2: Figure S1.
More than half (55.2 %) the upregulated genes in
enriched GO categories corresponded to cell metabolism
and transporters. Thus, genes involved in the uptake and
degradation of neurotransmitters such as glutamate,
glycine and catecholamines were overexpressed after
treatment (Slc1a2, Glul, Gldc and Maob). Ion channels,
pumps and transporters with key homeostatic and meta-
bolic functions were also preferentially upregulated by
cAMP. For instance, genes participating in the mem-
brane transport of K+ (Kcnn2), Cl− (Clcn2), Ca2+
(Atp2a2 and Atp2b2), water (Aqp4), glucose (Slc2a1),
thyroid hormones (Slco1c1 and Slc16a2), and oligopep-
tides (Slc15a2) were activated by cAMP signaling. More-
over, an increase of cAMP levels induced expression of
genes coding for a wide variety of astrocytic metabolic
enzymes, such as most aldehyde dehydrogenases, tRNA
ribonucleases and GPI transamidases. Interestingly, the
third functional category of genes upregulated by cAMP
was associated with antioxidant activities (Table 1).
Thus, genes encoding for antioxidant enzymes and mol-
ecules, such as catalase, superoxide dismutases, metal-
lothioneins, heme oxygenases and NADPH-quinone
oxidoreductases were found to be through microarray
analysis. Enhanced cAMP also upregulated numerous
genes related to the glutathione system and transport of
antioxidant vitamins. These results support previous
studies showing an antioxidant involvement of the
cAMP pathway in the CNS and suggest that cAMP
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signaling promotes glial differentiation and antioxidant
protection [1, 20].
GO categories enriched with downregulated genes were
associated mainly with proliferating and immaturity-
related features of astrocytes (Table 2). Thus, 71.5 % of the
genes were involved in the general categories cell cycle
and apoptosis, cell signaling, cytoskeleton, cell shape and
motility, and cell development. Expression of genes typic-
ally involved in mitotic processes was dramatically de-
creased, such as those encoding for the DNA polymerases
and the proliferation antigen Mki67. Transcripts of prolif-
eration and cell death regulators, such as mitogens and
morphogens (IGF-1, PDGF and BMP4), cyclins, caspases
and proapoptotic Bcl2 family members (e.i., Casp8, Bid
and Bax) were reduced after exposure to cAMP. More-
over, numerous genes involved in cytoskeletal
organization, such as Rho GTPases, myosins, actins,
tropomyosins, kinesins and septins, were notably
repressed. Among downregulated genes, those GO cat-
egories associated with reactive astrocytes such as com-
ponents of the extracellular matrix and mediators of
the immune response were predominantly enriched.
Thus, mRNA expression of tenascin C, nidogens and
many collagens and chondroitin and heparan sulfate
proteoglycans was reduced. Interestingly, the enzymes
responsible for the major postranscriptional modifica-
tions of proteoglycans and collagens were widely down-
regulated (sulfotransferases and lysyl oxidases). Finally,
prolonged cAMP signaling stimulation in astrocytes
induced a downregulation of numerous mediators of
Fig. 1 Regulation of microarray expression in identified single astrocytes in culture. Double immunofluorescence confocal images of the astrocyte
marker GFAP (red) and three proteins differentially regulated by cAMP (green) in control and treated cells. Mki67 and Ssat were analyzed in permeabilized
astrocytes and NR2C in non-permeabilized cells. Nuclear Mki67 immunfluorescence was abundant in control astrocytes, but almost absent in cAMP-treated
cells. Diffuse cytosolic Ssat and extracellular clusters of NR2C were intensely labeled in treated cells. Yellow signal in the Ssat labeling indicates colocalization
with GFAP cytoskeleton. Note the star-shaped morphology acquired by astrocytes exposed to permeable cAMP agonists. Scale bar: 10 μm
Fig. 2 Validation of microarray expression data for selected differentially
expressed genes in cultured astrocytes at the mRNA and protein levels. a
Comparison of cDNA microarray and qRT-PCR data. b Western blotting
analysis of cAMP-regulated genes in control and treated astrocytes
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the immune response, such as cytokines, chemokines
and components of the major histocompatibility com-
plex and phagocytototic and adhesion processes (e.g.,
Tnf, Ccl2, Tgfb1, Cxcl10, Csf1r, H2-D1, B2m, Gulp1 and
Icam1). We conclude that cAMP contributes to the re-
striction of developmental and activation features of
astrocytes.
Elevated cAMP restricts the activation of astrocytes and
promotes their differentiation
To substantiate the net phenotype induction of cAMP
signaling on astroglial cells, we applied GSEA analysis to
contrast the present gene profiles with previous micro-
array studies describing the transcriptome signatures of
in vivo astrocytes acutely isolated in a range of states.
First, we compared our genome profiling results with
gene sets of developing and mature brain astrocytes
reported by Cahoy et al. [21]. We found that cAMP-
induced upregulated genes were significantly enriched
for the mature profile of astrocytes (Fig. 4). The 166
common transcripts included metabolic (Agxt2l1),
antioxidant (Sod3) and signaling (Gjb2). Conversely,
258 genes downregulated by cAMP, such as Pold1,
Ccna2 and Npy, were enriched for the developmental
gene set of astrocytes (Fig. 4). The full lists are shown
in Additional file 3: Table S2 and S3. We conclude
that cAMP signaling causes the global transcriptome
of astrocytes to become more differentiated. Previous
electrophysiological and biochemical studies demon-
strating that cAMP elevation induces the acquisition
of mature astrocyte signatures, such as proliferation
arrest, membrane conductances, neurotransmitter
uptake and cytoskeletal construction further substanti-
ate a relevant contribution of this pathway to astro-
cyte maturation [7–10]. In addition to supporting
roles to neurons, astrocytes are dynamic regulatory el-
ements implicated in the physiology of neural circuits
[1–3]. The observed regulation of connexins and pan-
nexins provides evidence for the crucial contribution
of intracellular cAMP levels to glial crosstalk. Inter-
estingly, cAMP augmentation also influences astroglial
components of the so-called “tripartite synapse”. Here
we show that the NMDA receptor subunit, NR2C,
and the SNARE proposed to mediate astrocyte-to-
neuron communication, VAMP-2 [22], were found to
be under control of cAMP concentrations. These
results together previous observations on regulated
exocytosis implicate cAMP as a second messenger
involved in neural communication [2, 17, 23].
Next, we compare our profiles of cAMP-regulated
genes with genes overexpressed in activated astrocytes.
First, we compared cAMP-regulated gene sets with
Table 1 Antioxidant-associated genes upregulated by cAMP in
astrocytes (fold-change)
Catalase Cat (2.2)
Superoxidase dismutases Sod2 (1.4), Sod3 (5.3)
Peroxiredoxins and
sulfiredoxins
Prdx1 (1.8), Prdx2 (1.5), Prdx5 (1.5),
Srxn1 (4.1)
Cystine/glutamate transporter Slc7a11 (9.6)
Glutamate-cysteine ligases Gclc (5.3), Gclm (3.1)
Gluthatione synthetase
and transferases
Gss (1.5), Gsta1 (15.7), Gsta2 (6.9),
Gsta3 (6.6), Gsta4 (2.3), Gstm5 (1.6),
Mgst1 (4.4), Mgst2 (7.7)
Glutathione peroxidases and
reductases
Gpx4 (1.6), Gsr (1.5)
NADPH-quinone oxidoreductase
and heme oxygenase
Nqo1 (4.4)
Thioredoxins and thioredoxin
reductases
Txn2 (1.6), Txnrd1 (3.3)
Metallothioneins and
selenoproteins
Mt1 (1.6), Mt2 (1.5), Sepp1 (1.3)
Ascorbate and glucose/
dehydroascorbate transporters
Slc23a2 (4.5), Slc2a1 (3.9),
Slc2a4 (1.4), Slc2a8 (1.7),
Slc2a13 (2.2)
α-tocopherol transfer protein Ttpa (2.2)
Fig. 3 Global GO classification of gene expression profile of cAMP-treated astrocytes. Pie charts depicting the relative proportions of significant up- and
downregulated genes in general categories containing distinctive GO terms. The GO analysis was performed using GSEA (http://software.broadinstitute.org/
gsea/index.jsp). Detailed GO terms are shown in Additional file 2: Figure S1
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previous studies performed on cultured astrocytes stim-
ulated with pro-inflammatory cytokines [24, 25]. It has
been established that in vitro administration of TNF-α,
IL-1β and IFN-γ recapitulate many aspects of reactive
astrogliosis, mainly those related to immunity processes
[26]. Genes downregulated by cAMP were significantly
enriched in upregulated gene sets of astrocytes treated
with IFN-γ alone (n = 313 genes) or with a mix of TNF-
α, IL-1β and IFN-γ (n = 183 genes) (Fig. 4a, c). Remark-
ably, more than a quarter of the genes upregulated by
each inflammatory treatment were downregulated by
cAMP. Gene sets downregulated by cAMP and upregu-
lated by IFN-γ alone and by the cytokine mix shared 17
genes in common, 11 related to immune response (i.e.
Ccl2, Icam1) and 4 to proteasomal and lysosomal com-
ponents (i.e., Ctsc). The full gene list is in Additional file
3: Table S4. Consistently, similar opposite gene regula-
tion was found comparing changes induced by cAMP
with those produced by the inflammatory mediators
TGF-β1, lipopolyssacaride (LPS) and IFN-γ on cultured
astrocytes reported by Hamby et al. [27].
We further evaluated the activation state of astrocytes
exposed to 8Br-cAMP comparing our results whit previ-
ous genomic analyses performed on reactive astrocytes
acutely isolated from ischemic and LPS-exposed mouse
brains [28]. As occurs in models of astrogliosis in vitro,
genes repressed by cAMP were significantly enriched in
activated gene sets of in vivo reactive astrocytes (Fig. 4a,
c). Among the genes showing an opposite regulation in
8Br-cAMP-treated cells and brain isolated reactive
astrocytes were those involved in cell cycle (Ccnb1,
Ccnd1, Gas1, Ki67), immune response (B2m, Ccl2, H2-
K1), extracellular matrix (Anxa1, Anxa2, Col6a1) and
cell signaling and metabolism (Cav1, Ch25h, Galntl2,
Igfbp3, Klf6, Tnfrsf12a). Stroke and neuroinflammation
induce overlapping but distinct sets of activated genes
in reactive astrocytes [28], thus around a third and
quarter of the genes upregulated in vivo by ischemia
and LPS, respectively, were significantly enriched for
the profile of repressed by cAMP signaling (Fig. 4c,
Additional file 3: Tables S5 and S6). Moreover, 7 out of
the 18 genes downregulated by cAMP and activated by
the two in vivo injury models were associated to
immune response (Cd14, Cxcl10, Gbp3, Icam1, Iigp1,
Oasl2 and Spp1). Taken together, these data indicate
that cAMP signaling restrict reactive astrogliosis.
Our findings demonstrate a wide cAMP-induced
downregulation of genes related to the main hallmarks
of astroglial activation, such as hyperplasia, cytoskeletal
rearrangement, triggering of immunological reactions
and production of scar components. Many genes associ-
ated with proliferation and cytoskeletal components
upregulated during activation were downregulated by
cAMP (as shown for Mki67 and Nes). This is expected
Table 2 Selected categories and genes down-regulated by cAMP elevation in astrocytes
General category
GO category NES FDR q-value Gene ID Protein name FC
Cell cycle and apoptosis
Mitosis −1,71 0.018 Ccna2 12428 cyclin A2 - 4,2
DNA directed DNA polymerase activity −1,76 0.012 Pold1 18971 polymerase (DNA directed), delta 1, catalytic subunit −2,3
Cytokinesis −1,69 0.02 Myh10 77579 myosin, heavy polypeptide 10, non-muscle −3,7
Cell signalling
Ras protein signal transduction −1,77 0.012 Igf1 16000 insulin-like growth factor 1 −6.1
Neuropeptide hormone activity −1,29 0.183 Npy 109648 neuropeptide Y - 3,5
Cytoskeleton, cell shape and motility
Collagen −1,75 0.013 Col5a2 12832 collagen type V a2 - 6,7
Structural constituent of cytoskeleton −1,67 0.023 Tpm1 22003 tropomyosin 1, alpha −3.1
Cell development
Cell development −1,85 0.008 Igfbp3 16009 insulin-like growth factor binding protein 3 - 4,1
Cellular metabolism
Proteoglycan metabolic process −1,76 0.012 Chst7 60322 chondroitin 6-sulfotransferase 7 - 2,9
Immune response
Inflammatory response −1,82 0.01 Ccl2 20296 chemokine (C-C motif) ligand 2 - 2,1
Cxcl10 15945 chemokine (C-X-C motif) ligand 10 −3,7
Others
Lipid raft −2,01 0.0088 Cav1 12389 caveolin 1 - 4,0
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because developing and reactive astrocytes share some
cellular features. Moreover, cAMP elevation also re-
presses a number of genes encoding for immunological
mediators and scar components which are overexpressed
in reactive astroglia (cytokines, chemokines, collagens,
sulfated proteoglycans and adhesion molecules), includ-
ing the new marker for reactive astrogliosis, podoplanin
[29]. Although some transcripts implicated in glial acti-
vation were upregulated in cultured cells treated with
8Br-cAMP (i.e. C3 and Il-6), our results suggest that
cAMP signaling essentially represses astroglial activation.
This conclusion may diverge from the assumption by
some authors that cAMP analogs in cultured astrocytes
promote activation [12–16]. However, this consideration
was taken on the basis of changes in shape stellation and
GFAP expression, which are also typical attributes of
maturing astrocytes [8, 9, 30]. Noteworthy, our results
showing an opposite transcriptome regulation by cAMP
and glial-activating cytokines are consistent with previ-
ous studies demonstrating that elevated cAMP in
Fig. 4 GSEA analysis comparing the gene profile of cAMP-treated astrocytes with the transcriptome signatures of astroglial cells in different states.
a The upregulated gene set identified in cAMP-treated astrocytes is significantly enriched in mature and in vivo astroglial cells, while the cAMP-induced
downregulated gene set is significantly enriched in developing, in vitro, proinflammatory cytokine-treated astrocytes and after MCAO and LPS treatment.
FDR q-value, False discovery rate; NES, Normalized Enrichment Score. b Representative GSEA analysis showing the plots of cAMP-regulated gene profile
with in vivo (n= 2821 genes) and in vitro (n= 2105 genes) gene sets obtained from Cahoy et al. 2008. Signal-to-Noise ratio statistic was used to rank the
genes on the basis of their correlation with either the upregulation (red) or downregulation (blue). On each panel, the vertical black lines indicate the
position of each gene of the set in the ordered, non-redundant data set. The green curve corresponds to the enrichment profile curve, which is the
running sum of the weighted enrichment score obtained with GSEA software. c Proportional Venn diagrams representing the overlap of astroglial genes
differentially expressed by cAMP compared to the gene sets in different astrocyte states (fold change cut-off 1.5 in each case except for LPS and MCAO
that fold-change cut off was 4)
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astrocytes antagonizes the cytokine-induced expression of
adhesion molecules involved in neuroinflammation [31]. A
repressive role for cAMP in glial activation is also consist-
ent with the observations that cAMP pathways are involved
in the reduction and promotion of the glial activation trig-
gered by anti-inflammatory and pro-inflamatory extracellu-
lar agents, respectively [32–34]. Moreover, the observation
of cAMP-induced upregulation of repressors of the glial
inflammatory response, such as Socs1 (2.3 fold) and Nr4a2
(10.5 fold) [35, 36], further support the notion that cAMP
signaling restrict glial activation.
cAMP signaling confers a in vivo-like transcriptional
profile to cultured astrocytes
In contrast to other neural cell types, such as neurons
and oligodendrocytes, astroglial cells grown in culture
do not accurately reflect their attributes in vivo. For in-
stance, cultured astrocytes display a high proliferative
rate and deficient glutamate clearance, and they lack
cell processes and membrane K+ and Cl− conductances
[7, 8]. It has been revealed that in vitro astrocytes show
an immature, somewhat reactive, transcriptional profile
[21, 37] (see also overlap between developing and in vitro
sets in Fig. 4c). Therefore by comparing our results with
gene sets of Cahoy et al. [21], we also examined whether
cAMP-induced changes make the features of cultured
astrocytes more like those observed in vivo. Surprisingly,
334 out of 1147 genes upregulated by cAMP were signifi-
cantly enriched in the mRNA signature of brain-purified
astrocytes (in vivo set), whereas a 32,5 % of cAMP-
downregulated genes were common with the upregulated
set of cultured astrocytes (in vitro set) (Fig. 4a-c). For
instance, the connexin Gja1, the immunosuppressor
Nr4a2, the antioxidant Cat and the Notch pathway
effector Hes5 were overexpressed by cAMP, whereas a
strong downregulation was found for many annexins,
caveolins and IGFBPs. The full gene lists are shown
in Additional file 3: Table S7 and S8. Moreover,
around two-thirds of the overlapped genes in the
cAMP-upregulated/mature and cAMP-downregulated/
developing groups were shared with in vivo (i.e.
Adra2a, Grin2c, and Kcnn2) and in vitro (i.e. colla-
gens, nidogens and kinesins) enriched gene sets,
respectively. Our observation that the transcriptome
of cultured astrocytes acquires a greater resemblance
to that of in vivo cells when these cells are exposed
to 8Br-cAMP may indicate that cAMP signaling con-
fers astrocytes an in vivo-like phenotype by repressing
activation and promoting differentiation. Because
astrocytes cultured in serum-free conditions and in a
bioactive3D system more closely resemble astrocytes
in vivo [38, 39], an involvement of cAMP signaling in
the environment-dependent acquisition of a in vivo
phenotype of cultured astrocytes could be suggested.
A transcriptional database of cAMP-regulated genes
involved in astrocyte maturation
We have contrasted our gene profiles with previous
studies describing the transcriptome signatures of
acutely isolated astrocytes [21, 28]. Next, we evaluate
expression of representative genes regulated by cAMP in
situ in cortical astrocytes in different states. Mki67 and
Nes genes were downregulated by cAMP in our cultures
(−5 and −4.2 fold), but upregulated in acute-purified
developing and reactive astrocytes [21, 28]. Conversely,
mRNA expression of the NMDA receptor subunit NR2C
was upregulated by cAMP (3.9 fold) as well as in isolated
matured astrocytes [21]. In agreement with the proliferative
state of cells, many nuclei of GFAP- and Nestin-positive
astrocytes were immunolabeled for Mki67 in histological
sections of postnatal and injured adult cortex, but not in
the intact adult brain (Fig. 5). Although recent studies have
shown that NR2C mRNA increases with age in cortical
astrocytes in situ [40, 41], the location of NMDA receptor
protein in glial cells in vivo is unknown. Here we show the
protein expression of NR2C subunit in many astrocytes in
the adult cerebral cortex (Fig. 5). In conclusion, the present
GSEA results may provide a comprehensive database of
transcripts involved in the acquisition of a mature astrocyte
phenotype regulated by the cAMP pathway.
The induction of target genes and cellular programs
regulated by the cAMP pathway is highly dependent on
cellular contexts [42]. For instance, elevated cAMP
results in cell-cycle arrest in astrocytes but induces pro-
liferation of neurons [9, 43]. We postulate that the
potent gene regulation by cAMP in astrocytes shown
here is conveyed through PKA and the subsequent acti-
vation of the CREB transcription factors. Moreover, the
recruitment of specific CREB regulatory partners, the
activation of PKA-independent pathways and a second-
ary gene regulation may also collaborate to shape the
individual astrocyte transcriptome elicited by cAMP
signaling [43, 44].
Conclusions
We here show that the net effect of cAMP signaling is
to restrict developmental and activation features of
astrocytes and promote their maturation. Therefore, we
propose that controlled positive modulation of cAMP
signaling could be used to repress the mechanisms of
activation driven by pathological situations and to pro-
mote the physiologically normal state of differentiated
astrocytes to support and protect neuronal populations.
Methods
Animals
OF1 mice were provided by Charles River Laboratories,
Inc. (Lyon, France), kept under controlled temperature
(22 ± 2 °C), humidity (40–60 %), and light (12-h cycles)
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and treated in accordance with the European Commu-
nity Council Directive (86/609/EEC) on animal welfare.
Under ketamine/xylazine anesthesia, stab wound lesions
were made in the parietal cortex with a scalpel blade as
described previously [19].
Astrocyte cultures
Cultures were prepared from the cerebral cortex of 2-
day-old mice [17]. Most cell culture reagents were
obtained from GIBCO (Invitrogen, Paisley, UK). Briefly,
the cerebral cortex was isolated and the meninges were
carefully dissected out. Cortical tissues were then
minced and incubated in 0.25 % trypsin and 0.01 %
DNase. Dissociated cells were seeded in flasks and
grown in high-glucose Dulbecco’s Modified Eagle’s
Medium and F-12 (1:1) containing 10 % FBS, 10 mM
HEPES and penicillin/streptomycin at 37 ° C in a 5 %
CO2 incubator. At confluence (days 10–12), the flasks
were shaken overnight and the cells were rinsed,
detached and subcultured onto poly-L-lysine-coated
plastic culture dishes and coverslips. Treatment with
1 mM 8Br-cAMP (Biolog, Life Science Institute,
Bremen, Germany) was administered for 8 days to
induce the robust morphological and physiological
changes described elsewhere [7, 8].
RNA Extraction and Reverse Transcription
RNA was isolated from triplicate cultures from the four
individual experiments. Extractions were performed
using using Trizol® Reagent (Invitrogen™) following the
manufacturer’s instructions. The quantity and quality of
isolated RNAs were determined with a NanoDrop ND-
1000 (NanoDrop Technologies, Wilmington, DE, USA)
and a Bioanalyzer 2100 (Agilent, Waldbronn, Germany).
The RNA integrity numbers (RIN) in all cases ranged from
8.7 to 10, thereby indicating minimal RNA degradation
[45]. First-strand DNA was synthesized using the Super-
script III Reverse Transcriptase kit (Invitrogen). 1 μg of
total RNA was added to kit components and nuclease-free
water to 20 μl. Reactions containing nuclease-free water in-
stead of enzyme served as a negative control. Reactions
were incubated at 25 °C for 10 min, 50 °C for 30 min, 85 °C
for 5 min. They were then chilled on ice. E.coli RNAse H
was added and incubated at 37 °C for 20 min. The samples
were then cooled to 4 °C and finally stored at −20 °C.
Microarray Analysis
RNA (500 ng) was labeled using Agilent’s Low Input
RNA Labeling Kit, which involves reverse transcribing
the mRNA in the presence of T7-oligo-dT primer to
produce cDNA and then in vitro transcribing with T7
RNA polymerase in the presence of Cy3-CTP or Cy5-
CTP to produce labeled cRNA. The labeled cRNA was
hybridized to the Agilent Mouse 4x44K 60-mer oligo
microarray according to the manufacturer’s protocol.
The arrays were washed, dried by centrifugation and
scanned on an Agilent G2565BA microarray scanner at
100 % PMT and 5 μm resolution. Data were extracted
using Genepix 6.0 (Molecular Devices) software using
the irregular spot finding feature.
Microarray Statistical Processing
Log2ratio values were computed for all pairs of control
and cAMP-stimulated samples. Per-probe log2ratios
were aggregated to per-gene values by taking median
values. Analysis for differential expression on a gene-
by-gene basis was performed by limma [46] while
distinguishing biological from technical replicates (dye-
swap hybridizations). Correction for multiple testing
was done using the False Discovery Rate (FDR) method.
Additional file 1: Table S1 with heat map was generated
with Array File Maker 4.0 tool [47]. The lists of regu-
lated genes were brought into biological context by
Gene Ontology scoring using GSEA [48]. Also, for
cross-study comparisons GSEA, was applied. This
approach was used to test gene sets of interest (defined
as lists of differentially expressed gene symbols derived
from other studies) for significant enrichment among
Fig. 5 In situ expression of astroglial genes controlled by cAMP in the cerebral cortex in different states. Confocal images of double immunofluorescences
of Mki67, Nestin, NR2C and GFAP in the hippocampal dentate gyrus (Mki67/GFAP) and the stratum radiatum of the CA1 region (NR2C/GFAP), and upper
layers of neocortex (Mki67/Nestin) of postnatal and adult brains. Cortical lesions were analyzed 5 days after a stab wound injury in the contralateral
(control) and ipsilateral (lesion) hemispheres. Arrows point to identified astrocytes expressing only GFAP. Arrowheads identify double labeled cells. Crosses
and the asterisk indicate the lateral ventricle and the brain surface, respectively. Scale bar: 10 μm
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differentially expressed genes within our study. Only stud-
ies performed on mouse from which astrocyte cultures
were obtained and maintained under similar conditions to
those in the present study were considered. To compare
the gene sets by Venn diagrams, we fixed the same fold
change cut-off at 1.5.
Quantitative Real-Time PCR Analysis
RT-qPCR was carried out using Power SYBR® Green PCR
Master Mix (Applied Biosystems, Foster City, CA) on an
Applied 7700 machine, using the primers indicated in
Additional file 4: Table S9, and following the manufac-
turer’s protocol. A dilution series (100–10−3) of total
cDNA was prepared to determine the standard curve
(relative quantification). The samples (in triplicates) were
amplified according to the following protocol: 10 min at
95 °C, 42 cycles: 15 s at 95 °C, 15 s annealing temperature
(60 °C), 30 s at 72 °C. To control the specificity of the
reaction, melting-curve analysis was performed after
amplification. In addition, PCR products were analyzed by
agarose gel electrophoresis to confirm the size of the ampli-
fied targets. Levels of Tbp were used as normalization
controls and relative mRNA levels were calculated as indi-
cated by Pfaffl et al. [49] and expressed as mean ± standard
error.
Western blotting
Cultured cells were lysed in ice-cold 50 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 %
Triton-X 100 and protease inhibitor cocktail (Roche
Diagnostics). Samples were electrophoresed in 10 %
SDS-PAGE (BioRad) and then transferred to nitrocellu-
lose membranes (Whatman® Schleicher & Schuell,
Keene, NH). The membranes were blocked in a solution
containing 5 % non-fat milk powder in TBST (140 mM
NaCl, 10 mM Tris/HCl, pH 7.4 and 0.1 % Tween 20) for
1 h at room temperature and then incubated with pri-
mary antibodies (Additional file 5: Table S10) in blocking
buffer for 2 h at room temperature. After several washes
in blocking solution, the membranes were incubated for
1 h with HRP-conjugated secondary antibodies (DAKO,
Glostrup, Denmark). Bound antibodies were visualized
with enhanced chemiluminescence reagents PIERCE®
ECL Western Blotting Substrate (Thermo Scientific,
Rockford, IL, USA).
Immunocytochemistry
Cells grown on glass coverslips were fixed with 4 % para-
formaldehyde in PBS for 15 min. Adult and postnatal (P5)
animals were perfused transcardially under deep
anesthesia with the same fixative. Brains were removed
from the skulls, postfixed for 4 h and cryoprotected over-
night at 4 °C by immersion in a 30 % sucrose solution.
Forty-micrometer-thick frozen sections were obtained
with a cryostat and collected in PBS. To suppress non-
specific binding, cell cultures and brain sections were
incubated in PBS containing 10 % FBS, 0.1 % Triton X-
100, 0.2 % glycine, and 0.2 % gelatin for 1 h at room
temperature. Incubations with the primary antibodies
(Additional file 5: Table S10) were carried out overnight
at 4 °C in PBS containing 1 % FBS, 0.1 % Triton X-100,
and 0.2 % gelatin. Cell cultures and brain sections were
processed for immunofluorescence using secondary
fluorochrome-conjugated antibodies (Alexa Fluor 488
and Alexa Fluor 568, Molecular Probes, Eugene, OR).
Cell nuclei were stained with 4′,6-diamidino-2-pheny-
lindole (DAPI, Molecular Probes). Cell-containing
coverslips and histological sections were mounted with
Mowiol. Double immunofluorescences were performed
by using primary antibodies raised in different species.
Images were obtained with a Leica TCS SPE scanning
confocal microscope. The specificity of the immuno-
staining was tested by omitting the primary antibodies
or by replacing them with an equivalent concentration
of nonspecific IgG. No immunostaining was observed
in these conditions.
Ethics statement
Animal experimental procedures were approved by the
Ethics Committee of the Universitat de Barcelona, in
compliance with Catalan and European legislation All
efforts were made to minimize the number used and
animal suffering.
Additional files
Additional file 1: Table S1. Full list of significantly regulated genes in
cAMP-treated cells. Differential expression analysis on a gene-by-gene
basis was done using linear models (limma). The table contains all genes
with FDR q-values <5 % and absolute fold changes > 1.2 and is sorted on
the basis of fold changes in decreasing order. The first eight columns
show a color representation of the log2ratios for each two-color hybridization
of a cAMP-treated together with a control sample. The sign of dye-swap
hybridization log2ratios (indicated by ‘DS’ in the column name) was flipped,
such that values have the same “direction” as in the direct hybridizations, i.e.
red (green) indicates up- (down-) regulation in cAMP-treated as compared to
Control. The 9th column is the average log2ratio between cAMP-treated and
Control samples. In addition to gene symbol and gene description, the
remaining three columns show (symmetric) fold changes, limma p-values and
FDR q-values. (XLS 4198 kb)
Additional file 2: Figure S1. Barplot of enriched Gene Ontology
categories. The barplot shows negative log10 q-values of Gene Ontology
categories significantly enriched (q-value <0.02) with regulated genes
according to GSEA analysis. The greater the bar height, the more significant
the enrichment of the respective GO category. The vertical line indicates a
q-value of 0.02. Enrichment analysis was done separately for downregulated
genes (green bars) and upregulated genes (red bars). Categories are
grouped into the three ontologies, as indicated within the bar labels (MF:
Molecular Function, CC: Cellular Component, BP: Biological Process).
The bar widths are proportional to the numbers of genes associated
with the respective GO categories. The solid-colored part of the bars
indicates the fraction of genes within the “core enrichment” of the
respective category, as defined by GSEA analysis. (PDF 49 kb)
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Additional file 3: Tables S2–S8. Lists of genes regulated in cAMP-
treated cells and present in published astrocyte signatures. Genes that
are regulated in cAMP-treated cells (genes within the “core enrichment”
as defined by GSEA analysis), and that are reported to be regulated in
previously published astrocyte signatures: developing (Table S2), mature
(Table S3), cytokine-treated (Table S4), LPS (Table S5), MCAO (Table S6), in
vivo (Table S7) and in vitro (Table S8) astrocytes. The lists represent the
respective intersections in the Venn diagrams of Figure 4C. In GSEA
analysis, genes were ranked on the basis of signal-to-noise ratio within
the microarray data, starting with strongly upregulated and ending with
strongly downregulated genes. The third column of the tables indicate
the rank of the respective gene, i.e. low rank values indicate strong
upregulation and high ones close to the maximal value of 21,492 indicate
strong downregulation. (XLS 108 kb)
Additional file 4: Table S9. Primers used in this study. (XLSX 11 kb)
Additional file 5: Table S10. Antibodies used in this study. (XLSX 11 kb)
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